Sugammadex and Heart Failure

PHASE3CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2012

Study Completion Date

April 30, 2012

Conditions
Postoperative Neuromuscular Block
Interventions
DRUG

Sugammadex

After the induction of anaesthesia, monitoring neuromuscular function is initiated and performed continuously using the TOF-Watch SX (Organon Ireland Ltd, Ireland) at the thumb. Repetitive train-of four (TOF) stimulation is applied every 15 s at the ulnar nerve until the end of anaesthesia, at least until recovery of the TOF ratio to 0.9 after administration of sugammadex. Each patient receives a single IV bolus dose of rocuronium 0.6 mg kg-1, after which tracheal intubation is performed. Maintenance doses of rocuronium 0.1 mg kg-1, are permitted as required and administered at the reappearance of the second twitch in the TOF. On reappearance of the second twitch at the end of surgery, patients receive a single IV bolus dose of sugammadex, 2.0 mg kg-1, for reversal.

Trial Locations (1)

9300

OLV Hospital, Aalst

All Listed Sponsors
lead

Onze Lieve Vrouw Hospital

OTHER

NCT01509651 - Sugammadex and Heart Failure | Biotech Hunter | Biotech Hunter